id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0423-0005,FDA,FDA-2006-N-0423,Supporting Statement for Infectious Disease Issues in Xenotransplantation (DUPLICATE),Supporting & Related Material,Statement (Supporting and Related Material),2007-02-07T05:00:00Z,2007,2,,,2025-06-18T23:24:24Z,,0,0,09000064804618c8
FDA-2006-N-0423-0006,FDA,FDA-2006-N-0423,Supporting Statement for Infectious Disease Issues in Xenotransplantation (DUPLICATE),Supporting & Related Material,Statement (Supporting and Related Material),2007-02-07T05:00:00Z,2007,2,,,2025-06-18T23:25:27Z,,0,0,09000064804618ca
FDA-2006-N-0423-0007,FDA,FDA-2006-N-0423,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Infectious Disease in Xenotransplantation,Notice,Notice of Approval,2007-02-07T05:00:00Z,2007,2,2007-02-01T05:00:00Z,,2025-06-18T23:11:04Z,E7-1550,0,0,09000064804618cb
FDA-2006-N-0423-0004,FDA,FDA-2006-N-0423,Supporting Statement for Infectious Disease Issues in Xenotransplantation,Supporting & Related Material,Statement (Supporting and Related Material),2007-02-07T05:00:00Z,2007,2,,,2025-06-18T23:22:33Z,,0,0,09000064804618c7